Mice depleted of ␥␦ T cells by in vivo administration of anti-TCR␥␦ monoclonal antibodies showed susceptibility against an intravaginal infection with herpes simplex virus type 2 (HSV-2). The systemic Th1 response was impaired in the ␥␦ T-cell-depleted mice. Mice deficient in the V␦1 T subset were susceptible to an intravaginal infection with HSV-2. Intraepithelial ␥␦ T cells bearing V␦1 may help protect against intravaginal infection with HSV-2 through promoting the systemic Th1 response.
T-cell receptor (TCR) ␥␦ T cells are present only in small numbers in peripheral lymphoid tissues but are abundant in intraepithelial lymphocytes in the skin, intestines, and reproductive organs such as the uterus and vagina (3, 5) . The intraepithelial ␥␦ T-cell subsets in the mouse model bear invariant TCRs, including the V␦1 subset that comprises most of the ␥␦ T cells in the skin and the female reproductive tract (3, 5) . Animal models of infection with herpes simplex virus type 2 (HSV-2) have demonstrated that protective mechanisms against primary infection with HSV-2 are mainly mediated by class II-restricted CD4 ϩ Th1 cells secreting gamma interferon (IFN-␥) (7, 10, 11, 14, 17) . TCR ␥␦ T cells are reported to play important roles in protection against systemic infection with HSV-1 in mice (15, 16) and to respond to acute vaginal infection with HSV-2 (12, 13) . However, the role of the intraepithelial ␥␦ T cells in intravaginal infection with HSV-2 is not yet elucidated. In this study, we examined the susceptibility of mice harboring a mutated TCR␦ chain constant gene or V␦1 gene to intravaginal infection with HSV-2.
Female C57BL/6 mice were purchased from Japan SLC (Hamamatsu, Japan). All mice were used at 5 to 6 weeks of age. In order to synchronize their estrous cycle at the progesterone-dominant stage, all mice were injected subcutaneously with 0.1 g of ␤-estradiol 17-cypionate (Sigma) 5 days before infection. Mice were injected intravaginally with various doses of the 186 strain of HSV-2 (9, 20) in 20 l of phosphatebuffered saline. In some experiments, 300 g of anti-TCR␥␦ monoclonal antibody (MAb) (UC7-13D5) or isotype control hamster immunoglobulin G was administered to mice 2 days before an intravaginal challenge with HSV-2. Vaginal wash fluids from six mice were individually assayed for virus infectivity. Uterine and vaginal intraepithelial lymphocytes (r-IEL) were prepared as described previously (12, 18) . For flow cytometric analysis, r-IEL were stained with biotin-conjugated anti-CD3ε MAb, fluorescein isothiocyanate-conjugated anti-TCR␣␤ MAb, and phycoerythrin-conjugated anti-TCR␥␦ MAb (PharMingen, San Diego, Calif.) and then were stained with Red-613-conjugated streptavidin (Life Technologies, Gaithersburg, Md.). The stained cells were analyzed by a FACSCalibur flow cytometer (Becton Dickinson, San Jose, Calif.). To determine the V␦ repertoire, total RNA was extracted from r-IEL by the acid-guanidium phenol-chloroform method. cDNA synthesis and PCR were performed by using a cDNA cycle kit (Invitrogen Corp., San Diego, Calif.). RNA was primed with 6.7 pmol of ␦ chain C region (C␦) primers in 20 l of reaction mixtures for reverse transcription. The C␦ and 5Ј V␦ primers were described previously (8) . PCR products (4 l) were subjected to electrophoresis on a 1.5% agarose gel (Gibco) and transferred to a Gene Screen Plus filter (New England Nuclear, Boston, Mass.). The Southern blots of PCR products were hybridized with J␦1 or J␦2 oligonucleotide probes, which were labeled with [␥-32 P]ATP by using a Megalabel 5Ј-labeling kit (Takara Shuzo Co. Ltd., Kyoto, Japan) according to the manufacturer's instructions. The r-IEL were cultured with anti-CD3 MAb (145-2C11; 100 g/ml) or anti-TCR␥␦ MAb (100 g/ml) that had been immobilized on the plates by prior incubation for 1 h. To estimate cytokine production, the supernatants were collected after a 48-h culture. The cytokine activity in the cell-free culture supernatants was assayed by an enzyme-linked immunosorbent assay (ELISA) with mouse IFN-␥ (Genezyme Diagnostics, Cambridge, Mass.). The CD4 ϩ T cells (more than 95% purity) were purified from spleen cells by using an autoMACS cell sorter (Miltenyi Biotec, Bergisch Gladbach, Germany) and were cultured in 200 l of complete culture medium in 96-well flat-bottom plates (Falcon; Becton Dickinson Ltd., Oxford, United Kingdom) at a density of 5 ϫ 10 5 cells/well, with the same number of mitomycin-treated spleen cells from C57BL/6 mice with or without 2.5 ϫ 10 4 PFU of heat-inactivated HSV-2 (56°C for 1 h). The mutant mouse (F 2 interbred from 129/Ola ϫ C57BL/6) strain deficient in the V␦1 gene (V␦1 Ϫ/Ϫ ) was generated by gene targeting, as described previously (4), and backcrossed with C57BL/6 mice more than eight times. The C57BL/6 background mutant mouse deficient in the TCR␦ chain constant gene (TCR␦ Ϫ/Ϫ ) was kindly provided by S.
Itohara (Riken, Saitama, Japan) (6). The statistical significance of the data was determined by Student's t test, except for lethality data, which were analyzed by the generalized Wilcoxon's test.
Accumulation of IFN-␥-producing ␥␦ T cells in the uterus and vagina following intravaginal HSV-2 infection.
We monitored the kinetics of ␥␦ T cells in the uterus and vagina following an intravaginal inoculation with HSV-2. The absolute numbers of ␥␦ T cells in the uterus and vagina increased to a peak on day 3 in C57BL/6 mice after HSV-2 infection ( Reverse transcription-PCR analysis showed that the ␥␦ T cells on day 3 preferentially used the V␦1-rearranged J␦1 gene, similar to those used by the ␥␦ T cells in noninfected control mice (Fig.  1B) . We also found V␦4-rearranged J␦1, which has been reported for accumulations in the uterus and vagina after infection (13) . Early production of IFN-␥ has an important role in determining whether naive CD4
ϩ T cells will differentiate into Th1 cells (2, 18) . We next examined the IFN-␥ production by ␥␦ T cells accumulated in the uterus and vagina following HSV-2 infection. IFN-␥ production by the ␥␦ T cells in the uterus and vagina was significantly augmented on day 3 in response to immobilized anti-CD3 MAb or anti-TCR␥␦ MAb (Fig. 1C) . There was no interleukin-4 production in response to TCR stimulation (data not shown). Thus, the number of ␥␦ T cells with V␦1 and with a high ability to produce IFN-␥ increased in the uterus and vagina following HSV-2 infection.
Susceptibility of mice depleted of ␥␦ T cells to intravaginal infection with HSV-2. To define the roles of ␥␦ T cells in protection against primary intravaginal infection with HSV-2, we examined the effects of in vivo depletion of ␥␦ T cells by anti-TCR␥␦ MAb on the survival rate of mice after intravaginal inoculation with HSV-2 strain 186. We confirmed that the numbers of ␥␦ T cells were severely reduced in uterine IEL and spleen cells on day 7 after HSV-2 infection when 300 g of anti-TCR␥␦ MAb was administered 3 days prior to infection ( Fig. 2 ; data not shown). As shown in Fig. 2A , all mice given anti-TCR␥␦ MAb died by day 16, and 60% of the mice given control MAb survived beyond 18 days (P Ͻ 0.01 by the generalized Wilcoxon's test). We compared virus titers in the organs of control mice and mice given anti-TCR␥␦ MAb on day 7 after infection with HSV-2 wild-type strain 186 (5 ϫ 10 3 PFU), at which time mice began to die. As shown in Fig. 2C , in mice given anti-TCR␥␦ MAb, larger amounts of infectious virus were detectable in the vaginal wash fluids of mice given anti-TCR␥␦ MAb (P Ͻ 0.01). Thus, these results indicated that mice given anti-TCR␥␦ MAb were susceptible to HSV-2 infection. To compare the HSV-2-specific Th1 cell responses of control mice and mice depleted of ␥␦ T cells after an intravag- T cells in response to heat-inactivated HSV-2 on day 7 after an intravaginal infection with HSV-2. As shown in Fig. 3 , IFN-␥ production by CD4 ϩ T cells from mice depleted of ␥␦ T cells was significantly lower than that in control mice (P Ͻ 0.05).
Susceptibility of V␦1 ؊/؊ mice to intravaginal infection with HSV-2. We next examined the survival rates of TCR␦ Ϫ/Ϫ mice or V␦1 Ϫ/Ϫ mice after an intravaginal infection with HSV-2. As shown in Fig. 4 , all of the TCR␦ Ϫ/Ϫ mice and 90% of the V␦1 Ϫ/Ϫ mice died by 11 days, while 40% of their littermates survived beyond 18 days (P Ͻ 0.05 by the generalized Wilcoxon's test). Thus, mice deficient in whole ␥␦ T cells and those deficient in V␦1 cells were equally susceptible to an intravaginal infection with HSV-2.
Protective mechanisms against HSV infection are mediated by two major waves of host responses. The first one, innate immunity, depends mainly on the phagocyte system and NK and NKT cells (1) . The second mechanism, acquired immunity, depends on the immune response mediated by T-helper type 1 cells of CD4 ϩ ␣␤ T cells that are indispensable in protection against systemic HSV infection (6, 14). We also confirmed that mice depleted of TCR␣␤ T cells by in vivo treatment with anti-TCR␣␤ MAb and TCR␤ Ϫ/Ϫ mice are highly susceptible Early production of IFN-␥ has an important role in determining whether naive CD4 ϩ T cells will differentiate into Th1 cells (2, 19) . The results of the present study showed that epithelial ␥␦ T cells in the uterus and vagina are activated to produce IFN-␥ during the course of HSV-2 infection and that mice deficient in the intraepithelial ␥␦ T cells bearing V␦1 showed a high susceptibility to the infection. Furthermore, mice depleted of ␥␦ T cells showed an impaired CD4 ϩ Th1 response following HSV-2 infection. Thus, these results suggest that the intraepithelial ␥␦ T cells may not only function in the front lines of host defense but also may help protect against HSV-2 infection by promoting a systemic CD4 ϩ Th1 response to HSV-2. ϩ/ϩ mice (10 mice in each group) were inoculated with 250 PFU of HSV-2 strain 186 and were monitored for survival. *, statistically significant difference from littermates for each group (P Ͻ 0.05 by the generalized Wilcoxon's test).
